Connect Biopharma Holdings Limited (Connect Biopharma Holdings Limi) aksje
CNTB
Sanntid$2.1700-0.1700 (-7.26%)
Laster graf...
Connect Biopharma Holdings Limi
Market Cap
$136,631,568
Åpning2.3400
Høy2.3600
Lav2.1700
Volum134.34k
P/EN/A
Markedsverdi136.63M
52-ukers høy3.8200
52-ukers lav0.7300
Gj.sn. volum269.72k
UtbytteN/A
BetaN/A
EPS-1.1500
Om Connect Biopharma Holdings Limited (Connect Biopharma Holdings Limi) aksje
Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.
Selskapsinformasjon
Børs: NasdaqGM (NGM)
Sektor: Sundhed
Industri: Bioteknologi
Adresse:
3580 Carmel Mountain Road
92130 San Diego, United States
92130 San Diego, United States
Telefon: + 877 245 2787
Nettside: https://www.connectbiopharm.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Anbefaling:1.00 - Stærk køb
Laveste kursmål
4.00
↑ 84.3%
Gjennomsnittlig kursmål
7.07
↑ 225.9%
Median kursmål
7.00
↑ 222.6%
Høyeste kursmål
10.00
↑ 360.8%